Tyebally Sara, Ghose Aruni, Chen Daniel H, Abiodun Aderonke T, Ghosh Arjun K
Cardio-Oncology Service, Barts Heart Centre, St Bartholomew's Hospital London, UK.
Oncology Department, St Bartholomew's Hospital London, UK.
Eur Cardiol. 2022 May 31;17:e15. doi: 10.15420/ecr.2021.45. eCollection 2022 Feb.
Chest pain is one of the most common presenting symptoms in patients seeking care from a physician. Risk assessment tools and scores have facilitated prompt diagnosis and optimal management in these patients; however, it is unclear as to whether a standardised approach can adequately triage chest pain in cancer patients and survivors. This is of concern because cancer patients are often at an increased risk of cardiovascular mortality and morbidity given the shared risk factors between cancer and cardiovascular disease, compounded by the fact that certain anti-cancer therapies are associated with an increased risk of cardiovascular events that can persist for weeks and even years after treatment. This article describes the underlying mechanisms of the most common causes of chest pain in cancer patients with an emphasis on how their management may differ to that of non-cancer patients with chest pain. It will also highlight the role of the cardio-oncology team, who can aid in identifying cancer therapy-related cardiovascular side-effects and provide optimal multidisciplinary care for these patients.
胸痛是就医患者最常见的症状之一。风险评估工具和评分有助于对这些患者进行快速诊断和优化管理；然而，尚不清楚标准化方法能否对癌症患者及其幸存者的胸痛进行充分分诊。这令人担忧，因为鉴于癌症与心血管疾病之间存在共同的风险因素，癌症患者的心血管死亡率和发病率往往会增加，此外，某些抗癌治疗与心血管事件风险增加相关，且这种风险在治疗后可能持续数周甚至数年。本文描述了癌症患者胸痛最常见病因的潜在机制，重点强调其管理方式与非癌症胸痛患者的差异。本文还将强调心脏肿瘤学团队的作用，该团队可协助识别与癌症治疗相关的心血管副作用，并为这些患者提供最佳的多学科护理。
